Lorbrena® (lorlatinib)
for Lung Cancer

Lorbrena (lorlatinib) is a prescription medicine used to treat metastatic non-small cell lung cancer (NSCLC) with an abnormal ALK gene. It’s an antineoplastic agent that works by slowing or stopping the growth of cancer cells, which are then destroyed by the body.

Heart